What did we learn from our first workshop? Check out this week's blog post to see whether our first workshop was successful or not. Drop your comments at the bottom of the blog or reach out on our contact page.
ARC maps cancer disparities across Appalachia: higher mortality, weaker screening and survival, and major theranostics access and workforce gaps.
Appalachia’s cancer burden is higher, but theranostics access lags: distance, workforce shortages, and referral gaps still shape who gets care.
Don’t let referral myths block care: this guide shows when to send patients for Pluvicto or Lutathera and what clinical signals should prompt early action.
Understanding the key players and their roles within a theranostic environment is critical to a successful program.
A clear theranostics referral path starts with PSMA PET, current labs, and treatment history—so eligible prostate cancer patients aren’t missed or delayed.
In Appalachia, the distance between a cancer diagnosis and the best available treatment isn't measured in miles alone, it is measured in workforce gaps, missing infrastructure, and training that never reached the community.
The appalachian radiotheranostic coalition (ARC) is a new regional initiative that hopes to increase awareness, education, and adoption of theranostics in the applachian region. This initiative is being created to serve as a blueprint for easy rollout into other areas across the United States and globally.
